AkzoNobel and Axalta Shareholders Approve Equal Merger

AkzoNobel and Axalta shareholders have overwhelmingly approved an equal merger valued at approximately $25 billion. Regulatory approvals are still pending, with completion expected between late 2026 and early 2027.